It is incumbent on melanoma and radiation oncology researchers alike to further our understanding of when and how RT can help patients.
Christopher A. Barker, MD
Advertisement
Articles by Christopher A. Barker, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
2
FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC
3
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
4
Targeting KRAS in Pancreatic Cancer: What is Daraxonrasib’s Mechanism of Action?
5